RXR activating molecules

Details for Australian Patent Application No. 2002254171 (hide)

Owner MAXIA PHARMACEUTICALS, INC.

Inventors Fanjul, Andrea; Tachdjian, Catherine; Pleynet, David, P., M.; Al-Shamma, Hussien, A.; Fine, Richard; Guo, Jianhua; Jakubowicz-Jaillardon, Karine; Spruce, Lyle, W.; Pfahl, Magnus; Zapf, James, W.

Agent Griffith Hack

Pub. Number AU-A-2002254171

PCT Pub. Number WO2002/072543

Priority 60/274,342 08.03.01 US

Filing date 8 March 2002

Wipo publication date 24 September 2002

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002254171

30 October 2003 Change of Name(s) of Applicant(s), Section 104

  Maxia Pharmaceuticals, Inc. The name of the applicant has been changed to Incyte San Diego, Inc.

18 December 2003 Amendment Made

  The nature of the amendment is: Add co-inventors Jakubowicz-Jaillardon, Karine and Guo, Jianhua.

22 January 2004 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Sep 2003

1 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002254172-SYSTEM AND METHOD FOR FUSION-ALIGNED REPROJECTION OF INCOMPLETE DATA

2002254170-HIGH RESOLUTION RESISTS FOR NEXT GENERATION LITHOGRAPHIES